Analysis of association between vitamin D metabolite concentration in blood plasma and pancreatic cancer. Experience of one center

Abstract

Introduction. An early detection of malignant neoplasms is of great practical importance for improvement of treatment results.

Objective. To analyze the levels of dehydrocholecalciferol in patients with different forms of malignant neoplasms of the pancreas and chronic pancrestitis.

Materials and methods. The cohort study enclosed the data from 160 patients, who were examined and treated in the Academician A.M. Granov Russian Scientific Center of Radiology and Surgical Technologies for the period from 2018 to 2022. The main group included 89 patients with morphologically confirmed diagnosis of the pancreatic cancer without metastases. The control group included 71 patient with the confirmed diagnosis of chronic pancreatitis. Vitamin D concentration was controlled prior to treatment.

Results. The size of the tumor node with the location of pathological process in the head of the pancreas varied from 2.1 to 6.3 cm. In the subgroup of patients with tumor lesion of the head of the pancreas, decompression of biliary ducts due to mechanical jaundice was implemented in 43 (82.6 %) persons. When comparing the indicators of 25(ОН)D concentration, in 36 (69.2 %) patients of the main group, different degrees of fall of vitamin D concentration in blood plasma were found. Most often a pronounced deficit of vitamin D was diagnosed in patients with the tumor localized in the head of the pancreas (8 (15.9 % patients). Out of 37 patients with localization of the tumor node in the body/tail, 25 (67.5 %) persons demonstrated normal values of blood plasma vitamin D and 12 (13.4 %) – different degrees of decrease in vitamin D concentration. A marked deficit of vitamin D was diagnosed in 2 (16.6 %) patients, deficit of vitamin D – in 7 (58.3 %), insufficiency – in 3 (25 %). In the control group, decrease in vitamin D level was determine in 12 (16.9 %) patients. An apparent deficit of vitamin D was diagnosed in 3 (4.2 %) patients, deficit of vitamin D– in 4 (5.6 %), and insufficiency of vitamin D – in 7 (9.8 %); normal values were registered in 57 (80.2 %) persons.

Conclusions. Taking into account the obtained data regarding a reliable association between the deficit and insufficiency of vitamin D and the cancer of the head of the pancreas as well as literature data, it is worthwhile to use this indicator as a marker of early detection of pancreatic cancer in risk group patients.

Keywords

pancreatic cancer / chronic pancreatitis / early detection / vitamin D

References

[1] American Cancer Society. Cancer facts & figures: Special section–Pancreatic cancer. Atlanta, GA 2013, available at: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2013.html.

[2] Pigarova E.A., Rozhinskaya L.YA., Belaya ZH.E., Dzeranova L.K., Karonova T.L., Il'in A.V., Mel'nichenko G.A., Dedov I.I. Klinicheskie rekomendacii Rossijskoj associacii endokrinologov po diagnostike, lecheniyu i profilaktike deficita vitamina D u vzroslyh. Problemy endokrinologii 2016; 62 (4): 60–61 (in Russian).

[3] Пигарова Е.А., Рожинская Л.Я., Белая Ж.Е., Дзеранова Л.К., Каронова Т.Л., Ильин А.В., Мельниченко Г.А., Дедов И.И. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых. Проблемы эндокринологии 2016; 62 (4): 60–61.

[4] Moiseenko V.E., Pavlovskij A.V., Popov S.A., Kovenko A.E., Solov'eva L.A., Semenov K.N., SHarojko V.V., Granov D.A. Vitamin D i rak podzheludochnoj zhelezy: vliyanie na onkogenez, perspektivy ispol'zovaniya v diagnostike i lechenii. Medicinskij alfavit 2022; 1 (5): 29–37 (in Russian).

[5] Моисеенко В.Е., Павловский А.В., Попов С.А., Ковенко А.Е., Соловьева Л.А., Семенов К.Н., Шаройко В.В., Гранов Д.А. Витамин D и рак поджелудочной железы: влияние на онкогенез, перспективы использования в диагностике и лечении. Медицинский алфавит 2022; 1 (5): 29–37.

[6] Apperly F.L. The relation of solar radiation to cancer mortality in North America. Cancer Res. 1941; 1: 191–195.

[7] Tran B., Whiteman D.C., Webb P.M., Fritschi L., Fawcett J., Risch H.A., Lucas R., Pandeya N., Schulte A., Neale R.E. Queensland Pancreatic Cancer Study Group. Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer. Cancer Epidemiol. 2013; 37 (6): 886–92. DOI: 10.1016/j.canep Giovannucci E., Liu Y., Rimm E.B.,

[8] Tran B., Whiteman D.C., Webb P.M., Fritschi L., Fawcett J., Risch H.A., Lucas R., Pandeya N., Schulte A., Neale R.E. Queensland Pancreatic Cancer Study Group. Association between ultraviolet radiation, skin sun sensitivity and risk of pancreatic cancer. Cancer Epidemiol 2013; 37 (6): 886–92. DOI: 10.1016/j.canep.2013.08.013

[9] Hollis B.W., Fuchs C.S., Stampfer M.J., Willett W.C. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98 (7): 451–459. DOI: 10.1093/jnci/djj101

[10] Giovannucci E., Liu Y., Rimm E.B., Hollis B.W., Fuchs C.S., Stampfer M.J., Willett W.C. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98 (7): 451–9. DOI: 10.1093/jnci/djj101

[11] May Cho, Parvin F Peddi, Kevin Ding, Ling Chen, Denise Thomas, Jian Wang, Albert C Lockhart, Benjamin Tan & Andrea Wang-Gillam. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. Journal of Translational Medicine 2013; 11: 206.

[12] May Cho, Parvin F. Peddi, Kevin Ding, Ling Chen, Denise Thomas, Jian Wang, Albert C Lockhart, Benjamin Tan & Andrea Wang-Gillam. Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma. Journal of Translational Medicine 2013; 11: 206.

[13] Pubudu Bulathsinghala, Kostas N. Syrigos, and Muhammad W. Saif. Role of Vitamin D in the Prevention of Pancreatic Cancer. J Nutr Metab. 2010; 2010: 721365.

[14] Pubudu Bulathsinghala, Kostas N. Syrigos, and Muhammad W. Saif. Role of Vitamin D in the Prevention of Pancreatic Cancer. J Nutr Metab 2010; 2010: 721365.

[15] Garland C.F., Garland F.C. Do sunlight and vitamin D reduce the likelihood of colon cancer. Int J Epidemiol 1980; 9 (3): 227–231. DOI: 10.1093/ije/9.3.227

[16] Easty D.J., Farr C.J., Hennessy B.T. New Roles for Vitamin D Superagonists: From COVID to Cancer. Front Endocrinol (Lausanne) 2021; (12): 644298. DOI: 10.3389/fendo.2021.644298

[17] Melek K.E., Hasan M., Seyda G., Mukremin U., Fatma Y.M., Hasan S. More sunlight exposure may improve the overall survival in patients with pancreas cancer. Journal of Oncological Sciences 2016; 2 (2–3): 73–76. DOI: 10.1016/j.jons.2016.08.002

[18] Waterhouse M., Risch H.A., Bosetti C., Anderson K.E., Petersen G.M., Bamlet W.R., Cotterchio M., Cleary S.P., Ibiebele T.I., La Vecchia C., Skinner H.G., Strayer L., Bracci P.M., Maisonneuve P., Bueno-de-Mesquita H.B., Zaton Ski W., Lu L., Yu H., Janik-Koncewicz K., Polesel J., Serraino D., Neale R.E. Pancreatic Cancer Case–Control Consortium (PanC4). Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. Ann Oncol 2015; 26 (8): 1776–1783. DOI: 10.1093/annonc/mdv236

[19] Korovina N.A., Zaharova I.N., Dmitrieva YU.A. Sovremennye predstavleniya o fiziologicheskoj roli vitamina D u zdorovyh i bol'nyh detej. Pediatriya. ZHurnal im. G.N. Speranskogo 2008; 87 (4): 124–129.

[20] Коровина Н.А., Захарова И.Н., Дмитриева Ю.А. Современные представления о физиологической роли витамина D у здоровых и больных детей. Педиатрия. Журнал им. Г.Н. Сперанского 2008; 87 (4): 124–129.

[21] Zaharova I.N., YAblochkova S.V., Dmitrieva YU.A. Izvestnye i neizvestnye effekty vitamina D. Voprosy sovremennoj pediatrii 2013; 12: 20–25 (in Russian).

[22] Захарова И.Н., Яблочкова С.В., Дмитриева Ю.А. Известные и неизвестные эффекты витамина D. Вопросы современной педиатрии 2013; 12: 20–25.

[23] Suplotova L.A., Avdeeva V.A., Pigarova E.A., Rozhinskaya L.YA., Troshina E.A. Deficit vitamina D v Rossii: pervye rezul'taty registrovogo neintervencionnogo issledovaniya chastoty deficita i nedostatochnosti vitamina D v razlichnyh geograficheskih regionah strany. Problemy endokrinologi 2021; 67 (2): 84–92 (in Russian).

[24] Суплотова Л.А., Авдеева В.А., Пигарова Е.А., Рожинская Л.Я., Трошина Е.А. Дефицит витамина D в России: первые результаты регистрового неинтервенционного исследования частоты дефицита и недостаточности витамина D в различных географических регионах страны. Проблемы эндокринологи 2021; 67 (2): 84–92.

[25] Wolpin B.M., Ng K., Bao Y. Plasma

[26] Wolpin B.M., Ng K., Bao Y. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21 (1): 82–91. DOI: 10.1158/1055-9965.EPI-11-0836

[27] 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2012; 21 (1): 82–91. DOI: 10.1158/1055-9965.EPI-11-0836

[28] Forrest K.Y., Stuhldreher W.L. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011; 31: 48–54. 10.1016/j.nutres.2010.12.001.

[29] Forrest K.Y., Stuhldreher W.L. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31: 48–54.

[30] Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009; 19: 84–88. DOI: 10.1016/j.annepidem.2007.12.002.

[31] Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009; 19: 84–8.

[32] Kimmie Ng., Jeffrey A. Meyerhardt, Kana Wu, Diane Feskanich, Bruce W. Hollis, Edward L. GiovannucciCharles S. Fuchs. Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer. Journal of Clinical Oncology 2008; 26: 18.

[33] Kimmie Ng, Jeffrey A. Meyerhardt, Kana Wu, Diane Feskanich, Bruce W. Hollis, Edward L. GiovannucciCharles S. Fuchs. Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer. Journal of Clinical Oncology 2008; 26: 18.

[34] Klapdor S., Richter E., Klapdor R. Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res 1991; 32: 8–13.

[35] Klapdor S., Richter E., Klapdor R. Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res. 1991; 32: 8–13.

[36] Armstrong T., Strommer L., Ruiz-Jasbon F. Pancreaticoduodenectomy for peri-ampullary neoplasia leads to specific micronutrient deficiencies. Pancreatology 2007; 7: 37–44. DOI: 10.1159/000101876.

[37] Armstrong T., Strommer L., Ruiz-Jasbon F. Pancreaticoduodenectomy for peri-ampullary neoplasia leads to specific micronutrient deficiencies. Pancreatology 2007; 7: 37–44. DOI: 10.1159/000101876.

[38] Thilo Hackert, Kerstin Schütte and Peter Malfertheiner. The Pancreas: Causes for Malabsorption. Viszeralmedizin 2014; 30 (3): 190–197.

[39] Thilo Hackert, Kerstin Schütte and Peter Malfertheiner. The Pancreas: Causes for Malabsorption. Viszeralmedizin. 2014; 30 (3): 190–197.

[40] Wesa K., Cronin A., Segal N.H. Serum 25-hydroxy vimtain D (vit D) and surviavl in colorectal cancer (CRC): a retrospecitve analysis (abstract 3615). J Clin Oncol. 2010; 28: 289–295

[41] Wesa K., Cronin A., Segal N.H. Serum 25-hydroxy vimtain D (vit D) and surviavl in colorectal cancer (CRC): a retrospecitve analysis (abstract 3615). J Clin Oncol 2010; 28: 289–295.

[42] Newton-Bishop J.A., Beswick S., Randerson-Moor J. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol. 2009; 27: 5439–44. DOI: 10.1200/JCO.2009.22.1135

[43] Newton-Bishop J.A., Beswick S., Randerson-Moor J. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009; 27: 5439–44. DOI: 10.1200/JCO.2009.22.1135.

RIGHTS & PERMISSIONS

Eco-Vector